April 2009
Volume 50, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2009
Selective Treatment of Choroidal Neovascularization by Laser- Activated Gold Nanoparticles: First in vitro Results
Author Affiliations & Notes
  • N. Eter
    Ophthalmology,
    University of Bonn, Bonn, Germany
  • I. Hahn
    Ophthalmology,
    University of Bonn, Bonn, Germany
  • F. Levold
    Molecular Medicine and Experimental Immunology,
    University of Bonn, Bonn, Germany
  • J. Groll
    Institute for Textile Chemistry and Macromolecular Chemistry, RWTH Aachen, Aachen, Germany
  • H. Keul
    Institute for Textile Chemistry and Macromolecular Chemistry, RWTH Aachen, Aachen, Germany
  • G. Huettmann
    Institute for Biomedical Optics, University of Luebeck, Luebeck, Germany
  • T. Sandrock
    Ceram Optec GmbH, Bonn, Germany
  • C. Stute
    Ceram Optec GmbH, Bonn, Germany
  • E. Endl
    Molecular Medicine and Experimental Immunology,
    University of Bonn, Bonn, Germany
  • Footnotes
    Commercial Relationships  N. Eter, None; I. Hahn, None; F. Levold, None; J. Groll, None; H. Keul, None; G. Huettmann, None; T. Sandrock, Ceram Optec, E; C. Stute, Ceram Optec, E; E. Endl, None.
  • Footnotes
    Support  BMBF Grant NBT4_049
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 2081. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      N. Eter, I. Hahn, F. Levold, J. Groll, H. Keul, G. Huettmann, T. Sandrock, C. Stute, E. Endl; Selective Treatment of Choroidal Neovascularization by Laser- Activated Gold Nanoparticles: First in vitro Results. Invest. Ophthalmol. Vis. Sci. 2009;50(13):2081.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To establish a new treatment modality for choroidal neovascularization using laser-activated gold nanoparticles.

Methods: : Gold nanorods are synthesized and biofunctionalized for specific targeting of neovascular retinal endothelial cells. Cultured retinal endothelial cells and pigment epithelial cells are incubated with nanorods and treated by laser irradiation to create focused heat shocks due to the laser emission that is absorbed by the nanoparticles. Particle uptake is investigated using light and electron microscopy. Cell death and apoptosis are studied by Hoechst and cPARP staining. Systemic distribution of gold nanoparticles following intravenous application in mice is studied histologically.

Results: : Light microscopy and electron microscopy demonstrate binding and intracellular uptake of coated nanorods. Cell necrosis can be found immediately after laser irradiation, whereas a delayed effect can be induced with even lower laser intensity, as seen in apoptosis measurements after 24h. Cell damage is limited to nanorod targeted cells. Laser treatment modalities alone show no effect on viability of either retinal endothelial cells or pigment epithelial cells. Pharmacokinetic studies in vivo demonstrate that functionalization with PEG is crucial to bypass filter organs in the body and achieve circulation times of the particles, that are necessary for accumulating in the target tissue in the eye.

Keywords: choroid: neovascularization • apoptosis/cell death • laser 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×